Guided Therapeutics (GTHP) Interest Coverage Ratio (2010 - 2025)
Guided Therapeutics (GTHP) reported Interest Coverage Ratio of 3.86 for Q4 2025, up 81.21% on a YoY basis from 2.13 in Q4 2024, and down 2.63% sequentially from 3.76 in Q3 2025.
Guided Therapeutics (GTHP) Interest Coverage Ratio (2010 - 2025) Analysis & Trends
Guided Therapeutics (GTHP) has 16 years of Interest Coverage Ratio data on file, last reported at 3.86 in Q4 2025.
- For the quarter ending Q4 2025, Interest Coverage Ratio rose 81.21% year-over-year to 3.86; the trailing twelve-month figure through Dec 2025 stood at 3.84 (up 36.93% YoY), and the FY2025 full-year result was 0.14, down 13.58% from the prior year.
- Interest Coverage Ratio declined to 3.86 in Q4 2025, from 3.76 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.88 in Q4 2021 to a low of 20.54 in Q4 2024.
- A 5-year average of 5.22 and a median of 3.3 in 2024 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio soared 353.37% in 2021 and plunged 863.18% in 2022, its largest moves.
- Tracing GTHP's Interest Coverage Ratio over 5 years: stood at 0.88 in 2021, then sank by 317.93% to 1.92 in 2022, then tumbled by 39.35% to 2.68 in 2023, then tumbled by 666.49% to 20.54 in 2024, then surged by 81.21% to 3.86 in 2025.
- Business Quant data shows GTHP's Interest Coverage Ratio at 3.86 in Q4 2025, 3.76 in Q3 2025, and 4.86 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Guided Therapeutics | 21.96 Mn | 21.89 Mn | 458,000.00 | -3.86 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.86 |
| Sep 30, 2025 | -3.76 |
| Jun 30, 2025 | -4.86 |
| Mar 31, 2025 | -2.82 |
| Dec 31, 2024 | -20.54 |
| Sep 30, 2024 | -2.85 |
| Jun 30, 2024 | -8.73 |
| Mar 31, 2024 | -5.61 |
| Dec 31, 2023 | -2.68 |
| Sep 30, 2023 | -2.00 |
| Jun 30, 2023 | -13.09 |
| Mar 31, 2023 | -12.77 |
| Dec 31, 2022 | -1.92 |
| Sep 30, 2022 | -7.90 |
| Jun 30, 2022 | -2.80 |
| Mar 31, 2022 | -4.39 |
| Dec 31, 2021 | 0.88 |
| Sep 30, 2021 | -0.82 |
| Jun 30, 2021 | -1.78 |
| Mar 31, 2021 | -2.03 |